Glucotrack (GCTK) Preferred Stock Liabilities (2014 - 2018)

Glucotrack's Preferred Stock Liabilities history runs 5 years deep, the most recent figure standing at $13.4 million for Q3 2018.

• Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $13.4 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $13.4 million (changed 0.0% YoY) and the FY2017 annual result came in at $13.4 million, up 33.66% from the prior year.
• Preferred Stock Liabilities was $13.4 million for Q3 2018 at Glucotrack, roughly flat from $13.4 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $13.4 million in Q3 2017 and bottomed at $6.9 million in Q4 2015.
• A 5-year average of $10.6 million and a median of $10.9 million in 2016 frame the typical range for Preferred Stock Liabilities.
• Annual changes were most pronounced in 2015 — Preferred Stock Liabilities dropped 10.48% — and 2016, when it surged 44.75%.
• Glucotrack's Preferred Stock Liabilities stood at $7.7 million in 2014, then declined by 10.48% to $6.9 million in 2015, then surged by 44.75% to $10.0 million in 2016, then soared by 33.66% to $13.4 million in 2017, then changed by 0.0% to $13.4 million in 2018.
• Business Quant data shows GCTK's Preferred Stock Liabilities at $13.4 million in Q3 2018, $13.4 million in Q2 2018, and $13.4 million in Q1 2018.